Bioxytran, Inc. (OTCMKTS:BIXT) Short Interest Update

Bioxytran, Inc. (OTCMKTS:BIXT) was the recipient of a significant decrease in short interest in February. As of February 28th, there was short interest totalling 6,200 shares, a decrease of 13.9% from the February 13th total of 7,200 shares. Based on an average daily volume of 164,300 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are short sold.

Bioxytran Price Performance

Shares of OTCMKTS:BIXT opened at $0.17 on Wednesday. The company has a market cap of $15.33 million, a P/E ratio of -17.39 and a beta of 2.00. Bioxytran has a 1 year low of $0.06 and a 1 year high of $0.21. The stock’s fifty day moving average price is $0.10 and its 200-day moving average price is $0.09.

About Bioxytran

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company’s lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.